Therapeutic Synergistic Potential of Tribulus terrestris and Asparagus racemosus in Treating Hypogonadism in Orchiectomized Rats
- 1 October 2025
- journal article
- Published by Bentham Science Publishers Ltd. in Current Bioactive Compounds
- Vol. 21 (8) , 1-14
Abstract
Background: Testosterone, a major sex steroid hormone secreted in males, plays a vital role in androgenic and anabolic activities. A dysfunctional hypothalamic-pituitary-adrenal low testicular Leydig cell function can account for the reduction in testosterone levels. This condition is known as hypogonadism/androgen deficiency, a global health issue. Various studies conducted in the past have revealed that the likelihood of developing the disease increases with age. Reports suggest that an annual decline of 0.4-2% occurs, with a 6% incidence in middle-aged men. Orchiectomy-induced hypogonadism causes androgen deficiency in males. Testosterone has a shelf life of two days, so surgical procedure helps in the cessation of testosterone, leading to the same symptoms and conditions as observed in hypogonadism. This study aimed to evaluate, for the first time, the combined effects of Tribulus terrestris and Asparagus racemosus on their ability to treat hypogonadism. Methods: In this study, healthy male Wistar rats were acclimatized for one week and subjected to orchiectomy to induce hypogonadism. The animals were divided into five groups: normal control, disease control, standard (Tentex forte 400 mg/kg), Tribulus terrestris (400 mg/kg), and a combination of Tribulus terrestris (400 mg/kg) and Asparagus racemosus (600 mg/kg). Treatments were administered daily for 14 days. Body weight and blood samples were collected on days 1, 7, and 14 for analysis. Serum biochemical parameters, including testosterone levels assessed by LC-MS, were evaluated, along with histopathological examination of the prostate and seminal vesicles. Statistical analysis was performed using one-way ANOVA, followed by Bonferroni post hoc test, with significance set at p < 0.05. Results: The combination of Tribulus terrestris (TT) (400 mg/kg) and Asparagus racemosus (AR) (600 mg/kg/day), when compared to alone Tribulus terrestris extract (400 mg/kg) resulted in an improvement of testosterone levels compared to the standard drug, Tentex forte (400 mg/kg). Conclusion: Therefore, the combination of Tribulus terrestris and Asparagus racemosus can be a promising treatment choice for the effective treatment of hypogonadism in the future.Keywords
This publication has 53 references indexed in Scilit:
- Promising phytopharmacology, nutritional potential, health benefits, and traditional usage of Tribulus terrestris L. herbHeliyon, 2024
- Senescence and Late-Onset Hypogonadism2023
- An Insight of Phytochemicals of Shatavari (Asparagus racemosus)2023
- Adaptogenic property of Asparagus racemosus: Future trends and prospectsHeliyon, 2023
- Therapeutic potential of rutin in male infertility: A mini reviewJournal of Integrative Medicine, 2023
- The role of testosterone, the androgen receptor, and hypothalamic-pituitary–gonadal axis in depression in ageing MenReviews in Endocrine and Metabolic Disorders, 2022
- Evaluation and Management of Testosterone Deficiency: AUA GuidelineJournal of Urology, 2018
- Obesity and late-onset hypogonadismMolecular and Cellular Endocrinology, 2015
- Effects of Tribulus terrestris on endocrine sensitive organs in male and female Wistar ratsJournal of Ethnopharmacology, 2010
- A Comparative Study on Aphrodisiac Activity of Some Ayurvedic Herbs in Male Albino RatsArchives of Sexual Behavior, 2009